GO:1903348 positive regulation of bicellular tight junction assembly: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903348 describes any process that activates or increases the frequency, rate or extent of bicellular tight junction assembly.
• Tight junctions are apical junctional complexes that control paracellular permeability and cell polarity in epithelial and endothelial cells.
• Positive regulation involves coordinated remodeling of claudins, occludin, ZO proteins, and the actin cytoskeleton.
• Dysregulation of tight junction assembly contributes to barrier dysfunction in intestinal, renal, testicular, and neurological diseases.
• Key regulatory inputs include microbial and dietary signals, kinase cascades such as mTORC1/mTORC2, and polarity complexes.
• CRISPR-based knockout, knock-in, and overexpression models enable causal dissection of positive regulators of tight junction assembly.
Description
GO:1903348, positive regulation of bicellular tight junction assembly, is a Gene Ontology biological process term that captures any process which activates or increases the frequency, rate or extent of tight junction assembly. Tight junctions are the most apical intercellular junctions in epithelial and endothelial cells, forming a selectively permeable barrier that separates apical and basolateral membrane domains and regulates paracellular transport. Because barrier integrity is central to tissue homeostasis, understanding how tight junction assembly is positively regulated has broad implications for intestinal, renal, testicular, and neurovascular biology. Researchers study this term to identify the molecular signals, structural components, and cellular contexts that promote junction formation, and to link these mechanisms to human disease. This article integrates the QuickGO definition with verified PubMed literature to provide a research-grade overview of GO:1903348, its core mechanisms, key genes, disease relevance, and experimental strategies.
positive regulation of bicellular tight junction assembly At A Glance
| GO ID | GO:1903348 |
|---|---|
| GO term | positive regulation of bicellular tight junction assembly |
| Ontology | biological_process |
| Synonym | activation of tight junction assembly; activation of tight junction formation; positive regulation of tight junction formation; up regulation of tight junction assembly; up-regulation of tight junction assembly; upregulation of tight junction assembly; up regulation of tight junction formation; up-regulation of tight junction formation; upregulation of tight junction formation |
| Major function | Increases the frequency, rate or extent of tight junction assembly, thereby promoting barrier formation and maintenance. |
| Related cellular component | Bicellular tight junction (GO:0005923) |
| Related biological process | Tight junction assembly (GO:0120192); positive regulation of cell-cell junction assembly (GO:1901891) |
| Example regulators | Claudins, occludin, ZO proteins, Par3, Tiam1, adducins, mTORC1/mTORC2 |
| Disease relevance | Intestinal barrier dysfunction, renal tubular disorders, blood-testis barrier disruption, blood-brain barrier alterations |
What Is GO:1903348?
GO:1903348 is defined as any process that activates or increases the frequency, rate or extent of tight junction assembly. In other words, it encompasses positive regulatory inputs that promote the formation, maturation, or remodeling of bicellular tight junctions between adjacent cells. This term is a child of positive regulation of cell-cell junction assembly and is specific to tight junctions, which are apical junctional complexes composed of transmembrane proteins such as claudins and occludin, scaffold proteins such as ZO-1, and associated actin cytoskeleton.
Why Is positive regulation of bicellular tight junction assembly Important in Cell Biology?
Positive regulation of bicellular tight junction assembly is fundamental to tissue barrier function and cellular polarity, and its dysregulation is implicated in a wide range of human pathologies. Tight junctions control paracellular permeability in epithelia and endothelia, and their assembly must be precisely regulated during development, tissue repair, and immune responses. Understanding the positive regulatory mechanisms provides mechanistic insight into how barriers are established and maintained, and identifies candidate targets for therapeutic intervention in diseases characterized by barrier loss.
• Maintains epithelial and endothelial barrier integrity by promoting tight junction assembly.
• Regulates paracellular transport of ions, solutes, and water in tissues such as intestine and kidney.
• Supports blood-testis barrier function and spermatogenesis.
• Contributes to blood-brain barrier properties and neurovascular homeostasis.
• Is modulated by intestinal bacteria and dietary components, linking microbiome to barrier function.
• Involves polarity complexes such as Par3 and Tiam1 in epithelial remodeling.
• Requires dynamic actin cytoskeleton reorganization mediated by proteins like adducins.
• Dysregulation is associated with inflammatory, infectious, and neoplastic diseases.
• Provides a mechanistic framework for developing barrier-protective therapeutics.
• Serves as a model for studying cell-cell junction assembly and remodeling.
What Happens During positive regulation of bicellular tight junction assembly?
Initiation and membrane recruitment
In simple terms: Cells start building tight junctions by bringing the right proteins to the right place at the cell surface.
Positive regulation begins with signals that recruit tight junction components to the apical lateral membrane. Transmembrane proteins such as claudins and occludin are delivered to the membrane, where they engage in homophilic and heterophilic interactions across adjacent cells. Polarity complexes, including Par3, help define the apical domain and guide junction formation. This step is influenced by extracellular cues such as microbial and dietary factors that can promote barrier assembly.
Scaffold assembly and cytoskeletal coupling
In simple terms: Scaffold proteins link the junction proteins to the cell's internal skeleton to stabilize the junction.
Once transmembrane proteins are in place, scaffold proteins such as ZO-1 bind to their cytoplasmic tails and connect them to the actin cytoskeleton. Adducins regulate remodeling of apical junctions by modulating actin dynamics, thereby influencing the extent of tight junction assembly. This coupling is essential for junction stability and for transmitting mechanical forces that shape the junctional complex.
Signaling pathways that amplify assembly
In simple terms: Specific signaling pathways act as accelerators, boosting the assembly process.
Positive regulation often involves kinase signaling cascades. For example, the balance between mTORC1 and mTORC2 influences blood-testis barrier integrity, with mTORC1-mTORC2 imbalance compromising barrier function. In pancreatic cancer cells, Par3 interacts with Tiam1 to regulate invasion, highlighting how polarity signaling can impact junction dynamics. These pathways can increase the rate or extent of tight junction assembly in response to physiological or pathological stimuli.
Maturation and barrier sealing
In simple terms: The junction matures into a functional seal that controls what passes between cells.
As assembly proceeds, tight junction strands mature into a continuous network that restricts paracellular diffusion. Claudin-16 and claudin-19 are critical for tight junction function in the thick ascending limb of the kidney, where they regulate paracellular cation transport. In the blood-brain barrier, alterations in endothelial and glial cells can disrupt tight junction integrity, underscoring the importance of positive regulatory mechanisms for barrier maintenance. Maturation also involves dynamic remodeling in response to environmental signals.
Cross-talk with adherens junctions
In simple terms: Tight junctions do not form in isolation; they communicate with other cell-cell junctions.
Inhibiting cadherin function by dominant mutant E-cadherin expression increases the extent of tight junction assembly, indicating cross-talk between adherens junctions and tight junctions. This suggests that positive regulation of tight junction assembly can be influenced by the status of other junctional complexes, and that disrupting one junction type may promote assembly of another. Such interplay is important for understanding how cells coordinate overall junctional architecture.
Key Genes Involved in GO:1903348 positive regulation of bicellular tight junction assembly
The following genes and proteins are experimentally implicated in positive regulation of bicellular tight junction assembly or in tight junction assembly more broadly, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CLDN16 | Claudin-16, tight junction transmembrane protein; regulates paracellular cation transport in kidney | Mutations cause familial hypomagnesemia with hypercalciuria and nephrocalcinosis; model for tight junction function |
| CLDN19 | Claudin-19, tight junction transmembrane protein; partners with claudin-16 | Renal and ocular phenotypes; studied in thick ascending limb physiology |
| OCLN | Occludin, transmembrane tight junction protein | Marker of tight junction assembly; regulated by microbial and dietary factors |
| TJP1 | ZO-1, scaffold protein linking tight junction proteins to actin cytoskeleton | Central to junction assembly and remodeling; target for imaging and perturbation |
| CDH1 | E-cadherin, adherens junction protein; cross-talk with tight junctions | Dominant mutant increases tight junction assembly extent |
| PARD3 | Par3, polarity protein; interacts with Tiam1 | Regulates invasion in pancreatic cancer; impacts junction dynamics |
| TIAM1 | Tiam1, Rac1 guanine nucleotide exchange factor; binds Par3 | Modulates polarity and junction remodeling in cancer cells |
| ADD1 | Alpha-adducin, actin cytoskeleton regulator | Regulates remodeling of apical junctions in epithelial cells |
| ADD2 | Beta-adducin, actin cytoskeleton regulator | Contributes to junction remodeling |
| ADD3 | Gamma-adducin, actin cytoskeleton regulator | Contributes to junction remodeling |
| MTOR | mTOR kinase, central to mTORC1 and mTORC2 complexes | mTORC1-mTORC2 balance affects blood-testis barrier integrity |
| RPTOR | Raptor, mTORC1 component | Part of mTORC1; implicated in barrier regulation |
| RICTOR | Rictor, mTORC2 component | Part of mTORC2; implicated in barrier regulation |
| SOX4 | Transcription factor; overexpressed in Sertoli cells | Transcriptomic analysis highlights cell-to-cell interaction genes |
| SOX8 | Transcription factor; overexpressed in Sertoli cells | Transcriptomic analysis highlights cell-to-cell interaction genes |
| DMD | Dystrophin, cytoskeletal protein | Dystrophic mdx mice show blood-brain barrier alterations |
How Is positive regulation of bicellular tight junction assembly Regulated?
Positive regulation of bicellular tight junction assembly is controlled by multiple signaling inputs. The mTOR pathway is a key regulator: an imbalance between mTORC1 and mTORC2 can compromise blood-testis barrier integrity, indicating that balanced mTOR signaling supports barrier function. Polarity complexes involving Par3 and Tiam1 modulate junction dynamics and cell invasion, linking polarity signaling to tight junction regulation. Adducins regulate actin remodeling at apical junctions, thereby influencing the extent of assembly. Extracellular factors, including intestinal bacteria and dietary components, can also modulate tight junction permeability and assembly. Additionally, cross-talk with adherens junctions, as shown by dominant mutant E-cadherin increasing tight junction assembly, suggests that junctional status feeds back on tight junction regulation.
positive regulation of bicellular tight junction assembly and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CLDN16 | Familial hypomagnesemia with hypercalciuria and nephrocalcinosis | Knockout or knock-in mouse models; renal epithelial cell lines |
| CLDN19 | Renal and ocular disorders | Knockout or knock-in models; patient-derived cells |
| MTOR | Blood-testis barrier disruption during infection | mTORC1/mTORC2 perturbation in Sertoli cells; infection models |
| PARD3 | Pancreatic cancer invasion | Knockdown or knockout in pancreatic cancer cell lines; xenograft models |
| DMD | Duchenne muscular dystrophy with blood-brain barrier alterations | mdx mouse model; endothelial cell culture |
Intestinal barrier dysfunction and inflammation
Tight junction permeability is regulated by intestinal bacteria and dietary components, and dysregulation of positive regulatory mechanisms can lead to increased paracellular permeability, contributing to inflammatory bowel diseases and other intestinal disorders. Understanding how positive regulation of tight junction assembly is controlled may inform strategies to restore barrier function.
Renal tubular disorders
Claudin-16 and claudin-19 are essential for tight junction function in the thick ascending limb of the kidney, where they regulate paracellular cation transport. Mutations in these genes cause familial hypomagnesemia with hypercalciuria and nephrocalcinosis, highlighting the clinical importance of tight junction assembly and function in the kidney.
Blood-testis barrier disruption
Uropathogenic Escherichia coli infection compromises the blood-testis barrier by disturbing mTORC1-mTORC2 balance, leading to barrier disruption. This illustrates how pathogens can interfere with positive regulatory pathways that maintain tight junctions in the testis, with potential consequences for male fertility.
Blood-brain barrier alterations
Severe alterations of endothelial and glial cells in the blood-brain barrier of dystrophic mdx mice suggest that dystrophin deficiency affects tight junction integrity. This links positive regulation of tight junction assembly to neurovascular pathology and muscular dystrophy.
From positive regulation of bicellular tight junction assembly-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate gene reduce tight junction assembly? | CRISPR knockout in epithelial or endothelial cell lines |
| Does a specific mutation affect tight junction assembly? | Point mutation knock-in via CRISPR |
| Does tagging a junction protein alter its localization? | Tagged knock-in (e.g., fluorescent tag) |
| Does overexpression of a regulator enhance assembly? | CRISPR activation or cDNA overexpression |
| Which genes are required for barrier formation? | Genome-wide CRISPR library screening |
| How does a pathogen affect barrier integrity? | Infection models with barrier cells |
How to Study the positive regulation of bicellular tight junction assembly Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcriptome changes | Identify genes regulated during junction assembly |
| Proteomics | Protein composition and modifications | Map tight junction complex components |
| Live-cell imaging | Dynamic localization of junction proteins | Visualize assembly and remodeling |
| TEER | Barrier tightness | Quantify epithelial/endothelial barrier function |
| Paracellular tracer flux | Permeability to solutes | Assess tight junction sealing |
| Immunofluorescence | Protein localization at junctions | Confirm assembly status |
| CRISPR screening | Gene requirement for barrier formation | Identify positive regulators |
| Co-immunoprecipitation | Protein-protein interactions | Study junction complex assembly |
Transcriptomic profiling
RNA-seq can identify genes whose expression changes during tight junction assembly or in response to positive regulators. For example, transcriptomic analysis of overexpressed SOX4 and SOX8 in TM4 Sertoli cells highlighted cell-to-cell interaction genes, providing candidate regulators of junction assembly.
Proteomic and interactomic approaches
Proteomics can map the composition of tight junction complexes and identify post-translational modifications that accompany assembly. Interaction studies, such as those defining the Par3-Tiam1 interaction, reveal how polarity proteins associate with junctional components.
Imaging of junction assembly
Fluorescence microscopy and live-cell imaging of tagged junction proteins (e.g., ZO-1, occludin) allow real-time visualization of assembly and remodeling. Adducin-dependent remodeling of apical junctions was demonstrated using such imaging approaches.
Barrier function assays
Measurement of transepithelial electrical resistance (TEER) and paracellular tracer flux quantifies barrier integrity, providing functional readouts of tight junction assembly. These assays are widely used to study claudin-16/19 function and the effects of microbial and dietary factors.
How CRISPR Can Be Used to Study GO:1903348 positive regulation of bicellular tight junction assembly
Knockout
CRISPR knockout of candidate positive regulators (e.g., CLDN16, PARD3, ADD1) can test whether they are required for tight junction assembly. Loss-of-function studies in epithelial cells have revealed roles for adducins in junction remodeling and for polarity proteins in junction dynamics.
Point Mutation
Introducing disease-associated point mutations (e.g., in CLDN16 or CLDN19) via CRISPR allows precise modeling of how specific amino acid changes affect tight junction assembly and barrier function.
Knock-in
Knock-in of fluorescent or epitope tags into endogenous junction genes (e.g., TJP1, OCLN) enables tracking of protein localization and dynamics during assembly without overexpression artifacts.
Overexpression
CRISPR activation or cDNA overexpression can test whether increasing the level of a candidate regulator enhances tight junction assembly. For example, overexpression of SOX4 or SOX8 in Sertoli cells altered expression of cell-to-cell interaction genes, suggesting a regulatory role.
How EDITGENE Supports positive regulation of bicellular tight junction assembly Research
Researchers studying positive regulation of bicellular tight junction assembly-related genes often need to determine whether a candidate gene is causally involved in junction formation, barrier maintenance, or disease-associated barrier loss. EDITGENE provides comprehensive CRISPR-based services to enable such causal studies, from knockout and point mutation to knock-in, overexpression, and library screening, supported by bioinformatics analysis.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of bicellular tight junction assembly research.
Frequently Asked Questions About positive regulation of bicellular tight junction assembly
What is GO:1903348?
GO:1903348 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate or extent of tight junction assembly.
What genes are involved in positive regulation of bicellular tight junction assembly?
Genes such as CLDN16, CLDN19, OCLN, TJP1, CDH1, PARD3, TIAM1, ADD1, ADD2, ADD3, MTOR, RPTOR, RICTOR, SOX4, SOX8, and DMD have been implicated in tight junction assembly or related processes.
How is tight junction assembly regulated?
It is regulated by signaling pathways including mTORC1/mTORC2, polarity complexes such as Par3-Tiam1, actin cytoskeleton regulators like adducins, and extracellular factors such as intestinal bacteria and dietary components.
What diseases are associated with tight junction assembly defects?
Diseases include intestinal barrier dysfunction, renal tubular disorders (e.g., familial hypomagnesemia with hypercalciuria and nephrocalcinosis), blood-testis barrier disruption, and blood-brain barrier alterations.
What is the role of claudins in tight junction assembly?
Claudins are transmembrane proteins that form the backbone of tight junction strands; claudin-16 and claudin-19 are critical for paracellular cation transport in the kidney.
How can CRISPR be used to study tight junction assembly?
CRISPR knockout, point mutation, knock-in, and overexpression can test the causal role of specific genes in tight junction assembly and barrier function.
What methods measure tight junction assembly?
Methods include transepithelial electrical resistance (TEER), paracellular tracer flux, immunofluorescence, live-cell imaging, RNA-seq, proteomics, and CRISPR screens.
What is the difference between tight junction assembly and positive regulation of tight junction assembly?
Tight junction assembly refers to the process of forming the junction, while positive regulation of tight junction assembly refers to processes that increase the frequency, rate, or extent of that assembly.
Which signaling pathway is important for blood-testis barrier tight junctions?
The mTOR pathway, specifically the balance between mTORC1 and mTORC2, is important for blood-testis barrier integrity.
Can diet affect tight junction assembly?
Yes, dietary components and intestinal bacteria can regulate tight junction permeability and assembly.
Conclusion
GO:1903348, positive regulation of bicellular tight junction assembly, is a critical biological process that governs barrier formation and maintenance in epithelial and endothelial tissues. Its dysregulation is linked to diverse diseases, including intestinal, renal, testicular, and neurological disorders. Understanding the molecular players and signaling pathways that positively regulate tight junction assembly provides a foundation for therapeutic strategies aimed at restoring barrier function. CRISPR-based models and functional assays are powerful tools to dissect these mechanisms and identify new targets.
References
- 1. Ulluwishewa D et al.. 2011. Regulation of tight junction permeability by intestinal bacteria and dietary components.. J Nutr 141(5):769-76 PMID: 21430248
- 2. Troxell ML et al.. 2000. Inhibiting cadherin function by dominant mutant E-cadherin expression increases the extent of tight junction assembly.. J Cell Sci 113 ( Pt 6):985-96 PMID: 10683147
- 3. Hou J et al.. 2010. Claudin-16 and claudin-19 function in the thick ascending limb.. Curr Opin Nephrol Hypertens 19(5):483-8 PMID: 20616717
- 4. Lu Y et al.. 2021. Uropathogenic Escherichia coli Infection Compromises the Blood-Testis Barrier by Disturbing mTORC1-mTORC2 Balance.. Front Immunol 12:582858 PMID: 33679734
- 5. Guo X et al.. 2016. Par3 regulates invasion of pancreatic cancer cells via interaction with Tiam1.. Clin Exp Med 16(3):357-65 PMID: 26084985
- 6. Naydenov NG et al.. 2010. Adducins regulate remodeling of apical junctions in human epithelial cells.. Mol Biol Cell 21(20):3506-17 PMID: 20810786
- 7. Roumaud P et al.. 2019. Transcriptomic analysis of overexpressed SOX4 and SOX8 in TM4 Sertoli cells with emphasis on cell-to-cell interactions.. Biochem Biophys Res Commun 512(4):678-683 PMID: 30922563
- 8. Nico B et al.. 2003. Severe alterations of endothelial and glial cells in the blood-brain barrier of dystrophic mdx mice.. Glia 42(3):235-51 PMID: 12673830
